A novel type IIb l-asparaginase from Latilactobacillus sakei LK-145: characterization and application
Shiro Kato,Kazuya Tamura,Yuki Masuda,Morichika Konishi,Kazuya Yamanaka,Tadao Oikawa
DOI: https://doi.org/10.1007/s00203-024-03979-5
IF: 2.667
2024-05-19
Archives of Microbiology
Abstract:We succeeded in homogeneously expressing and purifying l- asparaginase from Latilactobacillus sakei LK-145 ( Ls -Asn1) and its mutated enzymes C196S, C264S, C290S, C196S/C264S, C196S/C290S, C264S/C290S, and C196S/C264S/C290S- Ls -Asn1. Enzymological studies using purified enzymes revealed that all cysteine residues of Ls -Asn1 were found to affect the catalytic activity of Ls -Asn1 to varying degrees. The mutation of Cys196 did not affect the specific activity, but the mutation of Cys264, even a single mutation, significantly decreased the specific activity. Furthermore, C264S/C290S- and C196S/C264S/C290S- Ls -Asn1 almost completely lost their activity, suggesting that C290 cooperates with C264 to influence the catalytic activity of Ls -Asn1. The detailed enzymatic properties of three single-mutated enzymes (C196S, C264S, and C290S- Ls -Asn1) were investigated for comparison with Ls -Asn1. We found that only C196S- Ls -Asn1 has almost the same enzymatic properties as that of Ls -Asn1 except for its increased stability for thermal, pH, and the metals NaCl, KCl, CaCl 2 , and FeCl 2 . We measured the growth inhibitory effect of Ls -Asn1 and C196S- Ls -Asn1 on Jurkat cells, a human T-cell acute lymphoblastic leukemia cell line, using l -asparaginase from Escherichia coli K-12 as a reference. Only C196S- Ls -Asn1 effectively and selectively inhibited the growth of Jurkat T-cell leukemia, which suggested that it exhibited antileukemic activity. Furthermore, based on alignment, phylogenetic tree analysis, and structural modeling, we also proposed that Ls -Asn1 is a so-called "Type IIb" novel type of asparaginase that is distinct from previously reported type I or type II asparaginases. Based on the above results, Ls -Asn1 is expected to be useful as a new leukemia therapeutic agent.
microbiology